Avego BioScience Capital

General InformationAvego BioScience Capital appears to be a deep-tech investment or operational vehicle focused on the biotech and longevity sector, though limited public information is currently available about its exact operational structure and scale.

Funding & FinancialsBased on available information, specific funding details for Avego BioScience Capital are not readily confirmed in public sources.

Leadership & TeamLeadership and team composition for Avego BioScience Capital could not be verified from current public sources.

Recent ActivityRecent activity and notable developments for this entity are not clearly documented in accessible public databases or news sources.

Highlights

Total Raised

—

Latest Round

—

Stage

—

deep-tech

Employees

—

Headquarters

—

News Coverage

2 articles

Last: 1mo ago

Talent Signals

—

SEC Filings

—

News Coverage 2

Deep1mo ago

Memento Medicines launches with $93M to fix retinal disease vasculature

Memento Medicines raised $93M Series A to advance a bispecific antibody that simultaneously activates Tie2 and blocks VEGF, a dual mechanism no approved retinal therapy currently uses.

Deep1mo ago

Memento launches $93M bispecific bet against retinal disease standard

Memento Medicines raised $93M to develop MMT-205, a dual-mechanism antibody challenging anti-VEGF monotherapy dominance in nAMD and DME markets worth billions annually.

Similar Companies 6

LARGO CLEAN ENERGY CORP.TREADSTONE TECHNOLOGIES, INC.QUINO ENERGY INC MUGRID ANALYTICS LONG HILL FUNDS FW1, LLC DAIRYLAND POWER COOPERATIVEPublic